Delivering on our commitment to provide evidence and resources that support Canada’s response to the opioid crisis continues to be a key priority for CADTH.
Over the summer we’ve answered a range of research questions related to the treatment of opioid use disorder and the use of drug and non-drug…
The 2018 CADTH Symposium will be held in Halifax, Nova Scotia from April 15 to 17, 2018.
The theme is Managing Health Technologies: Supporting Appropriate, Affordable, and Accessible Care.
Submission Deadline: Friday, October 27, 2017.
Questions may be sent by email to [email protected].
A draft report on Drugs for Type 2 Diabetes: Second- and Third-Line Therapy Review Update is now available for feedback from all interested stakeholders.
Project
Call for Feedback
Feedback Due By
Drugs for Type 2 Diabetes: Second- and Third-Line Therapy Review Update
2017-08-22
2017-09-06…
A draft report on Dental Amalgams Compared With Resin Composites is now available for feedback from all interested stakeholders.
Project
Call for Feedback
Feedback Due By
Dental Amalgams Compared With Resin Composites
2017-08-21
2017-09-05
Consultation Document
Product Type
Submit Stakeholder…
CADTH is pleased to announce the election of four new members to its Board of Directors effective July 11, 2017:
John Abbott, Jurisdictional (Atlantic Provinces)
Mitch Moneo, Jurisdictional (Western Provinces)
Ellen Pekilis, Public
Dr. Charmaine Roye, Health System.
The CADTH Board of Directors has…
See CDR Update 124 for important news and information regarding the CADTH Common Drug Review.
Read this month’s issue of New at CADTH. Here, you’ll find the latest information on our products and services, corporate news, and news flashes of upcoming events across Canada.
Read this month’s issue of New at CADTH. Here, you’ll find the latest information on our products and services, corporate news, and news flashes of upcoming events across Canada.
See CDR Update 122 for important news and information regarding the CADTH Common Drug Review.
A draft report on Proton Beam Therapy for the Treatment of Cancer in Children and Adults is now available for feedback from all interested stakeholders.
Project
Call for Feedback
Feedback Due By
Proton Beam Therapy for the Treatment of Cancer in Children and Adults
2017-06-02
2017-06-16…
For as many as one in four Canadians living with obstructive sleep apnea (OSA), their nightly ritual involves disturbed and restless sleep that leaves them exhausted during the day and facing a host of serious health problems.
Thankfully, a range of OSA treatment options is available, including…
Obstructive sleep apnea (OSA) is a sleep disorder that affects as many as one in four adults in Canada. Join us in person or online for a special event: Treating Obstructive Sleep Apnea – Recommendations and Real-World Application. We will review what the evidence and recommendations say, and…